No abstract available
MeSH terms
-
Adult
-
Aged, 80 and over
-
Antibodies, Monoclonal / adverse effects
-
Antibodies, Monoclonal / therapeutic use*
-
Antineoplastic Agents, Immunological / adverse effects
-
Antineoplastic Agents, Immunological / therapeutic use*
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Asparaginase / administration & dosage
-
Drug Evaluation
-
Drug Resistance, Neoplasm
-
Fatal Outcome
-
Female
-
Humans
-
Lymphoma, Extranodal NK-T-Cell / drug therapy
-
Male
-
Middle Aged
-
Molecular Targeted Therapy*
-
Nivolumab
-
Programmed Cell Death 1 Receptor / antagonists & inhibitors*
-
Programmed Cell Death 1 Receptor / immunology
-
Recurrence
-
Salvage Therapy
Substances
-
Antibodies, Monoclonal
-
Antineoplastic Agents, Immunological
-
PDCD1 protein, human
-
Programmed Cell Death 1 Receptor
-
Nivolumab
-
Asparaginase